Table 1 Results of the questionnaire survey showing the methodology of estimation of GFR in the UK CCLG centres
From: Estimation of renal function and its potential impact on carboplatin dosing in children with cancer
Centre | Radioisotope | Route of injection | No of samples | Early sampling (<2 h) | GFR estimation | Methodology | Correction factor |
|---|---|---|---|---|---|---|---|
1 | 51Cr-EDTA | Peripheral | 3 | Yes | Med Physics | Slope–intercept | BM |
2 | 51Cr-EDTA | Central | 2 | No | Biochemistry | Slope–intercept | Chantler |
3 | 51Cr-EDTA | Central | 2 | No | Biochemistry | Slope–intercept | Chantler |
4 | 51Cr-EDTA | Central | 4 | No | Med Physics | Slope–intercept | Chantler |
5 | 51Cr-EDTA | Peripheral | 4 | No | Med Physics | Slope–intercept | BM |
6 | 51Cr-EDTA | Both | 4 | Yes | Med Physics | Slope–intercept | BM |
7 | 51Cr-EDTA | Both | 3 | No | Med Physics | Slope–intercept | BM |
8 | 51Cr-EDTA | Both | 3 | No | Med Physics | Slope–intercept | Modification |
9 | 99mTc-DTPA | Both | 2 | No | Med Physics | Slope–intercept | None |
10 | 51Cr-EDTA | Both | 3 | No | Med Physics | Slope–intercept | Chantler |
11 | 51Cr-EDTA | Peripheral | 3 | No | Med Physics | Slope–intercept | BM |
12 | 51Cr-EDTA | Peripheral | 2 | No | Biochemistry | Slope–intercept | None |
13 | 51Cr-EDTA | Both | 2 | No | Biochemistry | Slope–intercept | Chantler |
14 | 51Cr-EDTA | Both | 3 | Yes | Med Physics | Slope–intercept | None |
15 | 51Cr-EDTA | Peripheral | 3 | No | Med Physics | Slope–intercept | None |
16 | 51Cr-EDTA | Both | 4 | No | Med Physics | Slope–intercept | BM |
17 | 99mTc-DTPA | Both | 2 | No | Med Physics | Slope–intercept | BM |
18 | 51Cr-EDTA | Both | 3 | Yes | Med Physics | In-house method | None |
19 | 51Cr-EDTA | Peripheral | 3 | Yes | Biochemistry | Slope–intercept | None |
20 | 51Cr-EDTA | Central | 4 | Yes | Med Physics | Slope–intercept | Chantler |
21 | 51Cr-EDTA | Peripheral | 3 | No | Med Physics | Slope–intercept | BM |
